Business Context and Reporting Period
This Form 8-K was filed by DaVita Health Care Partners Inc. on April 6, 2015. The report discloses a material event regarding the Centers for Medicare and Medicaid Services (CMS) final 2016 Medicare Advantage benchmark payment rates announced after the market close on April 6, 2015.
Key Financial Metrics
The filing does not provide current period revenue, profit, cash flow, or debt figures. It focuses on a projected financial impact for the upcoming year:
- Estimated 2016 Operating Income Impact: Approximately $50 million reduction.
- Estimated Rate Reduction: Approximately 2% for the Company's Health Care Partners (HCP) business.
- Industry Comparison: The industry average rate increase is approximately 1.25%.
Material Changes Versus Prior Period
The filing highlights a significant divergence between the Company's expected rate changes and the industry average. While the industry anticipates a 1.25% increase, DaVita expects a 2% reduction. This disparity is attributed to CMS modifications to the risk adjustment model calculation, specifically the full implementation of the 2014 CMS-HCC Risk Adjustment model, which negatively impacts providers with significant investments in wellness and prevention programs for chronic conditions.
Guidance, Outlook, and Risks
Outlook and Variability: Management notes that the final financial impact may vary based on the growth of HCP's Medicare Advantage patient volumes across markets and the benefit plan designs submitted to CMS.
Key Risks and Contingencies: The filing lists numerous risk factors, including:
- Downward pressure on commercial payor rates and patient volume.
- Reductions in government payment rates under Medicare ESRD and other programs.
- Impact of the 2015 Medicare Advantage benchmark structure.
- Legal compliance risks and potential investigations.
- Increased competition from other dialysis providers.
- Disruption from the HCP transaction and potential loss of key employees.
- Risks associated with international operations and capital investment.
Important Facts for Investor Verification
- Verify the final 2016 Medicare Advantage benchmark rates and their specific application to DaVita's HCP business.
- Monitor the actual growth of Medicare Advantage patient volumes to assess the accuracy of the $50 million operating income impact estimate.
- Review the benefit plan designs submitted by HCP's affiliated managed care plans to CMS.
- Assess the long-term financial impact of the 2014 CMS-HCC Risk Adjustment model on the Company's wellness and prevention investments.